Liver Cancer, Adult
Showing 1 - 25 of >10,000
Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- Colon Cancer Liver Metastases
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Liver Cancer, Adult Trial in Palo Alto, Philadelphia (3D-MPUS)
Not yet recruiting
- Liver Cancer, Adult
- 3D-MPUS
-
Palo Alto, California
- +1 more
Jan 18, 2023
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ECT204 T cells
-
Duarte, California
- +1 more
Jan 9, 2023
Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
Active, not recruiting
- Advanced Adult Primary Liver Cancer
- +3 more
- positron emission tomography
- computed tomography
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)
Terminated
- Hepatocellular Carcinoma
- +4 more
- Transarterial embolization
- Microwave Ablation
-
Charlotte, North CarolinaCarolinas Medical Center
Apr 20, 2022
Hepatobiliary Cancer, Cholangiocarcinoma, Liver Metastases Trial in Tampa (Resistance Training, Aerobic Training)
Recruiting
- Hepatobiliary Cancer
- +2 more
- Resistance Training
- Aerobic Training
-
Tampa, FloridaMoffitt Cancer Center
Jun 16, 2023
Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary
Suspended
- Adult Primary Hepatocellular Carcinoma
- +3 more
- sorafenib tosylate
- +2 more
-
Birmingham, Alabama
- +20 more
Aug 29, 2022
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma Trial (LioCyx-M, Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- LioCyx-M
- Lenvatinib
- (no location specified)
Jan 4, 2022
Adult Liver Carcinoma, Gastric Carcinoma, Malignant Solid Tumor Trial in Columbus (other, behavioral, procedure)
Recruiting
- Adult Liver Carcinoma
- +3 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 23, 2022
Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)
Not yet recruiting
- Cancer Risk
- +30 more
- Samples
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 14, 2022
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma Trial in
Completed
- Adult Hepatocellular Carcinoma
- +3 more
- Stereotactic Radiosurgery
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 6, 2021
Adult Hepatocellular Carcinoma, Metastatic Malignant Tumor in the Liver Trial in Los Angeles (Image-Guided Adaptive Radiation
Completed
- Adult Hepatocellular Carcinoma
- Metastatic Malignant Neoplasm in the Liver
- Image-Guided Adaptive Radiation Therapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 9, 2022
Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in
Recruiting
- Adult Primary Liver Cancer
- +2 more
- TSR-022 and TSR-042
-
Honolulu, HawaiiUniversity of Hawaii
Sep 22, 2021
HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- HCC
- Liver Cirrhosis
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Advanced Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Philadelphia (PD-0332991)
Active, not recruiting
- Advanced Hepatocellular Carcinoma
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 21, 2021
Acute-On-Chronic Liver Failure Trial in Shanghai (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- Acute-On-Chronic Liver Failure
- sequential adult left lateral lobe liver transplantation (SALT)
-
Shanghai, ChinaRenji Hospital, Shanghai Jiao Tong University, School of Medicin
Oct 3, 2023
Solid Tumor, Adult, Impaired Liver Function Trial in Amsterdam (ModraDoc006/r)
Withdrawn
- Solid Tumor, Adult
- Impaired Liver Function
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek
Oct 18, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +2 more
- sorafenib tosylate
- stereotactic body radiation therapy
-
Berkeley, California
- +50 more
Nov 17, 2022
Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)
Active, not recruiting
- Breast Cancer
- +11 more
- radionuclide imaging
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 20, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Nivolumab
- Relatlimab
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +74 more
Nov 11, 2022
Liver Cirrhosis, Liver Trial (Sequential Adult Left Lateral Liver Transplantation)
Not yet recruiting
- Liver Cirrhosis
- Liver
- Sequential Adult Left Lateral Liver Transplantation
- (no location specified)
Nov 22, 2023
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
- HCC
- +4 more
- Y90 radioembolization
-
Chicago, IllinoisNorthwestern University
Aug 27, 2021
Acute-On-Chronic Liver Failure, Chronic Liver Failure Trial (a single course of micro-encapsulated hepatocytes intraperitoneal
Not yet recruiting
- Acute-On-Chronic Liver Failure
- Chronic Liver Failure
- a single course of micro-encapsulated hepatocytes intraperitoneal transplantation therapy
- (no location specified)
Feb 13, 2023